FDA Approves Glaxo Non-Prescription Diet Drug
Posted on: Thursday, 8 February 2007, 12:00 CST
GlaxoSmithKline Consumer Healthcare has said that the FDA approved the weight loss product orlistat capsules for over-the-counter, making it the first non-prescription drug available for this indication in the US.
GlaxoSmithKline claims the drug helps people lose 50% more weight than diet alone. The drug is intended for people 18 and older to use along with a reduced-calorie, low-fat diet and exercise. The recommended dose of orlistat is one 60mg capsule three times a day with meals containing fat.
GSK will market over the counter orlistat under the brand name "alli". The drug is expected to be available in stores nationwide by summer 2007.
"I applaud the alli program for stressing the importance of a reduced-calorie, low-fat diet in conjunction with a weight-loss medicine proven to be safe and effective. This lines up with research that shows even modest gradual weight loss provides significant health benefits," commented Caroline Apovian, director of the Center for Nutrition and Weight Management, Boston Medical Center.
Source: Datamonitor
Related Articles
- Atkins Responds to Recent New England Journal of Medicine Weight-Loss Diets Study Results
- Imaging Results From the ADAGIO-LIPIDS Reveal That Effects of Rimonabant on Cardiometabolic Risk Profile Include Loss of Visceral Fat and Mobilization of Liver Fat
- Examine the Chinese Markets for Weight Loss Diet Products
- Quick Weight Loss Diet Revitalizes Health and Optimizes the Body's Detoxification System
- Liberty Diversified Holdings, Inc. Announces Plans to Assume Control of All Website Sales of Serotrim(R) Weight Loss Drink and the Serotonin Weight Loss Diet
- FDA Panel Endorses OTC Sale of Orlistat -- Fat-Blocking Pill Would Be New Dieting Weapon
- Corporate Wellness Programs Expected to Boost Online Weight Loss, Diet Services
- Which Diets Keep Fat Away? -- Weight Watchers Gets Long-Term Nod
- Corp. Wellness Programs Poised to Play Part in Online Weight Loss, Dieting Market
- Increasing the Protein Content in a Carbohydrate-Free Diet Enhances Fat Loss During 35% but Not 75% Energy Restriction in Rats
 |
 |
User Comments (0)
RSS Feeds